Pharmaceutical Biotechnology, Department of Pharmacy and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Department of Pharmaceutical Sciences, University of Vienna, 1090 Vienna, Austria.
ACS Biomater Sci Eng. 2024 Jan 8;10(1):99-114. doi: 10.1021/acsbiomaterials.2c00476. Epub 2022 Jul 8.
Protein therapeutics are of widespread interest due to their successful performance in the current pharmaceutical and medical fields, even though their broad applications have been hindered by the lack of an efficient intracellular delivery approach. Herein, we fabricated an active-targeted dual pH-responsive delivery system with favorable tumor cell entry augmented by extracellular pH-triggered charge reversal and tumor receptor targeting and pH-controlled endosomal release in a traceless fashion. As a traceable model protein, the enhanced green fluorescent protein (eGFP) bearing a nuclear localization signal was covalently coupled with a pH-labile traceless azidomethyl-methylmaleic anhydride (AzMMMan) linker followed by functionalization with different molar equivalents of two dibenzocyclooctyne-octa-arginine-cysteine (DBCO-RC)-modified moieties: polyethylene glycol (PEG)-GE11 peptide for epidermal growth factor receptor-mediated targeting and melittin for endosomal escape. The cationic melittin domain was masked with tetrahydrophthalic anhydride revertible at mild acidic pH 6.5. At the optimally balanced ratio of functional units, the on-demand charge conversion at tumoral extracellular pH 6.5 in combination with GE11-mediated targeting triggered enhanced electrostatic cellular attraction by the RC cell-penetrating peptides and melittin, as demonstrated by strongly enhanced cellular uptake. Successful endosomal release followed by nuclear localization of the eGFP cargo was obtained by taking advantage of melittin-mediated endosomal escape and rapid traceless release from the AzMMMan linker. The effectiveness of this multifunctional bioresponsive system suggests a promising strategy for delivery of protein drugs toward intracellular targets. A possible therapeutic relevance was indicated by an example of cytosolic delivery of cytochrome initiating the apoptosis pathway to kill cancer cells.
蛋白质疗法因其在当前药物和医学领域的成功表现而受到广泛关注,尽管它们的广泛应用受到缺乏有效细胞内递药方法的阻碍。在此,我们构建了一种主动靶向双重 pH 响应递药系统,该系统具有通过细胞外 pH 触发的电荷反转和肿瘤受体靶向增强的肿瘤细胞进入能力,并以无痕迹的方式进行 pH 控制的内涵体释放。作为一种可追踪的模型蛋白,具有核定位信号的增强型绿色荧光蛋白(eGFP)通过共价键与 pH 不稳定的无痕迹叠氮甲基甲基马来酸酐(AzMMMan)接头连接,然后用不同摩尔当量的两种二苯并环辛炔-八精氨酸-半胱氨酸(DBCO-RC)修饰物进行功能化:聚乙二醇(PEG)-GE11 肽用于表皮生长因子受体介导的靶向,以及蜂毒素用于内涵体逃逸。阳离子蜂毒素域被四氢邻苯二甲酸酐可逆掩蔽,在温和酸性 pH 6.5 下恢复。在功能单元最佳平衡的比例下,在肿瘤细胞外 pH 6.5 时按需进行电荷转换,再加上 GE11 介导的靶向作用,触发 RC 穿细胞肽和蜂毒素的增强静电细胞吸引力,如强烈增强的细胞摄取所证明。通过利用蜂毒素介导的内涵体逃逸和 AzMMMan 接头的快速无痕迹释放,获得了 eGFP 货物的成功内涵体释放和核定位。这种多功能生物响应系统的有效性表明了一种有前途的策略,可将蛋白药物递送至细胞内靶标。通过细胞溶质递送细胞色素 c 引发凋亡途径杀死癌细胞的实例表明了其潜在的治疗相关性。